SCHEMBL16933469

SCHEMBL16933469

CC(C)(NC(N)=O)c1cccc(Oc2cccc(C(=O)N3CCOCC3)c2)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.58
▸ RAB9A P51151 3/20 0.54
▸ F10 P00742 2/20 0.52
▸ ALDH1A1 P00352 2/20 0.49
▸ TSHR P16473 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ KMT2A Q03164 1/20 0.47
▸ PARP14 Q460N5 4/20 0.47
▸ PARP10 Q53GL7 4/20 0.47
▸ NR1H2 P55055 1/20 0.46
▸ NR1H3 Q13133 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ MAPT P10636 1/20 0.45
▸ CRHBP P24387 1/20 0.45
▸ HTT P42858 1/20 0.45
▸ CRHR2 Q13324 1/20 0.45
▸ PARP1 P09874 1/20 0.45
▸ NPC1 O15118 1/20 0.44
▸ TP53 P04637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15578345 0.83 L3MBTL1 (0.62) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL29384777 0.83 L3MBTL1 (0.62) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL16933440 0.81 HPGD (0.51) L3MBTL1RAB9AALDH1A1KMT2ASMN1; SMN2
SCHEMBL29387446 0.81 L3MBTL1 (0.48) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL16933575 0.81 L3MBTL1 (0.48) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL15577911 0.80 L3MBTL1 (0.47) L3MBTL1RAB9AALDH1A1
SCHEMBL15578307 0.79 RAB9A (0.46) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL15578152 0.79 L3MBTL1 (0.46) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL15578359 0.78 L3MBTL1 (0.57) L3MBTL1RAB9AF10ALDH1A1TSHR
SCHEMBL16933418 0.75 MLYCD (0.52) RAB9AALDH1A1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11008316-B2 Glucosylceramide synthase inhibitors GENZYME CORPORATION (US) 2021-05-18 — — US disclosed
US-20180065957-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GENZYME CORPORATION (US) 2018-03-08 — — US disclosed
US-20150210681-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GENZYME CORPORATION (US) 2015-07-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150210681-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GBA1, GBA2, GAA L3MBTL1 1688/4885RAB9A 699/4885F10 3367/4885
US-20180065957-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS GBA1, GBA2, GAA L3MBTL1 1688/4885RAB9A 699/4885F10 3367/4885
US-11008316-B2 Glucosylceramide synthase inhibitors GBA1, GBA2, GAA L3MBTL1 2336/4885RAB9A 641/4885F10 3023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback